Literature DB >> 19603488

Towards the elucidation of molecular determinants of cooperativity in the liver bile acid binding protein.

Massimo Pedò1, Mariapina D'Onofrio, Pasquale Ferranti, Henriette Molinari, Michael Assfalg.   

Abstract

Bile acid binding proteins (BABPs) are cytosolic lipid chaperones contributing to the maintenance of bile acid homeostasis and functional distribution within the cell. Liver BABPs act in parallel with ileal transporters to ensure vectorial transport of bile salts in hepatocytes and enterocytes, respectively. We describe the investigation of ligand binding to liver BABP, an essential step in the understanding of intracellular bile salt transport. Binding site occupancies were monitored in NMR titration experiments using (15)N-labelled ligand, while the relative populations of differently bound BABP forms were assessed by mass spectrometry. This site-specific information allowed the determination of intrinsic thermodynamic parameters and the identification of an extremely high cooperativity between two binding sites. Protein-observed NMR experiments revealed a global structural rearrangement which suggests an allosteric mechanism at the basis of the observed cooperativity. The view of a molecular tool capable of buffering against significant concentrations of free bile salts in a large range of solution conditions emerges from the observed pH-dependence of binding. We set to determine the molecular determinants of cooperativity by analysing the binding properties of a protein containing a mutated internal histidine. Both mass spectrometry and NMR experiments are consistent with an overall decreased binding affinity of the mutant, while the measured diffusion coefficients of ligand species reveal that the affinity loss concerns essentially one of the two binding sites. We therefore identified a mutation able to disrupt energetic communication functional to efficient binding and conclude that the buried histidine establishes contacts that stabilize the ternary complex. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19603488     DOI: 10.1002/prot.22496

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  6 in total

1.  Structural requirements for cooperativity in ileal bile acid-binding proteins.

Authors:  Serena Zanzoni; Michael Assfalg; Alejandro Giorgetti; Mariapina D'Onofrio; Henriette Molinari
Journal:  J Biol Chem       Date:  2011-09-14       Impact factor: 5.157

Review 2.  Bile acid binding protein: a versatile host of small hydrophobic ligands for applications in the fields of MRI contrast agents and bio-nanomaterials.

Authors:  Katiuscia Pagano; Simona Tomaselli; Serena Zanzoni; Michael Assfalg; Henriette Molinari; Laura Ragona
Journal:  Comput Struct Biotechnol J       Date:  2013-12-08       Impact factor: 7.271

3.  Ligand entry in human ileal bile acid-binding protein is mediated by histidine protonation.

Authors:  Gergő Horváth; Orsolya Egyed; Changguo Tang; Mihály Kovács; András Micsonai; József Kardos; Orsolya Toke
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

4.  The anti-inflammatory agent bindarit acts as a modulator of fatty acid-binding protein 4 in human monocytic cells.

Authors:  Sergio Oddi; Lucia Scipioni; Antonio Totaro; Clotilde Angelucci; Beatrice Dufrusine; Annalaura Sabatucci; Daniel Tortolani; Isabella Coletta; Maria Alessandra Alisi; Lorenzo Polenzani; Michael Assfalg; Carlo Caltagirone; Enrico Dainese; Mauro Maccarrone
Journal:  Sci Rep       Date:  2019-10-22       Impact factor: 4.379

Review 5.  Structural and Dynamic Determinants of Molecular Recognition in Bile Acid-Binding Proteins.

Authors:  Orsolya Toke
Journal:  Int J Mol Sci       Date:  2022-01-03       Impact factor: 5.923

6.  Multiple Timescale Dynamic Analysis of Functionally-Impairing Mutations in Human Ileal Bile Acid-Binding Protein.

Authors:  Gergő Horváth; Bence Balterer; András Micsonai; József Kardos; Orsolya Toke
Journal:  Int J Mol Sci       Date:  2022-09-26       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.